Treace Medical Concepts (TMCI)
(Delayed Data from NSDQ)
$8.44 USD
-0.01 (-0.12%)
Updated Jul 17, 2024 04:00 PM ET
After-Market: $8.42 -0.02 (-0.24%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
TMCI 8.44 -0.01(-0.12%)
Will TMCI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TMCI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TMCI
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates
LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates
TMCI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates
Globus Medical (GMED) Q4 Earnings and Revenues Beat Estimates
Other News for TMCI
TMCI Crosses Above Average Analyst Target
Treace Medical price target raised by $2 at Truist, here's why
Treace Medical Concepts: Facing Increasing Competitive Pressure
Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Treace Medical Concepts (TMCI) and Veeva Systems (VEEV)
Treace Medical director buys $253.5K in common stock